the company behind NEUROMARK, a minimally invasive solution to treat chronic rhinitis
Neurent Medical has raised €63M across 1 funding round from 7 investors, most recently a Series C round in Feb 2026. Based in Galway, Ireland; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-02-13 | Series C |
| €63M |
| Atlantic Bridge,Enterprise Ireland,EQT Life Sciences,Existing investors,Fountain Healthcare Partners,MVM Partners+1 more |
| View deal → |
